[ad_1]
Index to Management's Discussion and Analysis of Financial Condition and Results
of Operations
Page
Overview 36
Regulatory Developments 37
Summary of Critical Accounting Estimates 38
Non-GAAP Financial Disclosures 38
Results of Operations 40
Note Regarding Forward-Looking Statements 42
36
-------------------------------------------------------------------------------- Table of Contents For purposes of this discussion, "BHNY," the "Company," "we," "our" and "us" refer toBrighthouse Life Insurance Company of NY. BHNY is an indirect wholly-owned subsidiary of Brighthouse Financial, Inc. ("BHF" and together with its subsidiaries, "Brighthouse Financial"). This Management's Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with (i) the Interim Condensed Financial Statements and related notes included elsewhere herein; (ii) our Annual Report on Form 10-K for the year endedDecember 31, 2021 , filed with theU.S. Securities and Exchange Commission ("SEC") onMarch 3, 2022 (the "2021 Annual Report"); and (iii) our current reports on Form 8-K filed in 2022.
Overview
BHNY is aNew York stock life insurance company licensed to do business only in the state ofNew York . We market or administer a range of annuity and life insurance products to individuals and deliver our products through multiple independent distribution channels and marketing arrangements with a diverse network of distribution partners. We are organized into two segments: Annuities and Life. In addition, we report certain of our results of operations in Corporate & Other. See "Business - Segments and Corporate & Other" included in our 2021 Annual Report, as well as Note 2 of the Notes to the Interim Condensed Financial Statements for further information regarding our segments and Corporate & Other.
COVID-19 Pandemic
We continue to closely monitor developments related to the COVID-19 pandemic, which has negatively impacted us in certain respects. At this time, it continues to not be possible to estimate (i) the severity or duration of the pandemic, including the severity, duration and frequency of any additional "waves" or emerging variants of COVID-19 or (ii) the efficacy or utilization of any therapeutic treatments and vaccines for COVID-19 or variants thereof. It likewise remains not possible to predict or estimate the longer-term effects of the pandemic, or any actions taken to contain or address the pandemic, on the economy at large and on our business, financial condition, results of operations and prospects, including the impact on our investment portfolio and our ratings, or the need for us in the future to revisit or revise any targets we may provide to the markets or any aspects of our business model. See "Business - Regulation," "Risk Factors - Risks Related to Our Business - The ongoing COVID-19 pandemic could materially adversely affect our business, financial condition and results of operations, including our capitalization and liquidity" and "Management's Discussion and Analysis of Financial Condition and Results of Operations - Overview - COVID-19 Pandemic" included in our 2021 Annual Report, as well as Note 4 of the Notes to the Interim Condensed Financial Statements.
Regulatory Developments
We are domiciled inNew York and regulated by theNew York State Department of Financial Services . We are regulated primarily at the state level, with some products and services also subject to federal regulation. In addition, BHNY is subject to regulation under the insurance holding company laws of variousU.S. jurisdictions. Furthermore, some of our operations, products and services are subject to the Employee Retirement Income Security Act of 1974, consumer protection laws, securities, broker-dealer and investment advisor regulations, as well as environmental and unclaimed property laws and regulations. See "Business - Regulation," as well as "Risk Factors - Regulatory and Legal Risks" included in our 2021 Annual Report, as amended or supplemented by our subsequent Quarterly Reports under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations - Regulatory Developments."
Transition from LIBOR
OnMarch 15, 2022 , the Adjustable Interest Rate (LIBOR) Act (the "LIBOR Act") was signed into law, which provided a replacement framework for outstanding financial contracts tied to LIBOR once LIBOR ceases to be published. The LIBOR Act is substantially similar to the law passed inNew York inApril 2021 that aimed at ensuring legal clarity for legacy contracts governed byNew York law. The LIBOR Act provides a statutory mechanism and safe harbor that applies on a nationwide basis to replace LIBOR with a benchmark rate, selected by theFederal Reserve Board based on a secured overnight funding rate, for certain contracts that reference LIBOR and contain no or insufficient fallback provisions. The LIBOR Act preempts and supersedes any state or local law, statute, rule, regulation or standard relating to the selection or use of a benchmark replacement or related changes and allows parties that already have effective fallback provisions to opt out of the legislation. See "Business - Regulation - Transition from LIBOR" and "Risk Factors - Economic Environment and Capital Markets-Related Risks - We are exposed to significant financial and capital markets risks which may adversely affect our financial condition, results of operations and liquidity, and may cause our net investment income and our profitability measures to vary from period to period - Changes to LIBOR" included in our 2021 Annual Report, as amended or supplemented herein. 37
——————————————————————————–
Table of Contents
Summary of Critical Accounting Estimates
The preparation of financial statements in conformity with accounting principles generally accepted inthe United States of America ("GAAP") requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the Interim Condensed Financial Statements.
The most critical estimates include those used in determining:
•liabilities for future policy benefits;
•amortization of deferred policy acquisition costs (“DAC”);
•estimated fair values of freestanding derivatives and the recognition and
estimated fair value of embedded derivatives requiring bifurcation; and
•measurement of income taxes and the valuation of deferred tax assets.
In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations. Actual results could differ from these estimates.
The above critical accounting estimates are described in “Management’s
Discussion and Analysis of Financial Condition and Results of Operations –
Summary of Critical Accounting Estimates” and Note 1 of the Notes to the
Financial Statements included in our 2021 Annual Report.
Non-GAAP Financial Disclosures
Our definitions of non-GAAP financial measures may differ from those used by
other companies.
Adjusted Earnings In this report, we present adjusted earnings as a measure of our performance that is not calculated in accordance with GAAP. Adjusted earnings is used by management to evaluate performance and facilitate comparisons to industry results. We believe the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of our performance by contract holders by highlighting the results of operations and the underlying profitability drivers of our business. Adjusted earnings should not be viewed as a substitute for net income (loss), which is the most directly comparable financial measure calculated in accordance with GAAP. See "- Results of Operations" for a reconciliation of adjusted earnings to net income (loss). Adjusted earnings, which may be positive or negative, focuses on our primary businesses by excluding the impact of market volatility, which could distort trends.
The following are significant items excluded from total revenues in calculating
adjusted earnings:
•Net investment gains (losses);
•Net derivative gains (losses) except earned income and amortization of premium
on derivatives that are hedges of investments or that are used to replicate
certain investments, but do not qualify for hedge accounting treatment
(“Investment Hedge Adjustments”); and
•Certain variable annuity guaranteed minimum income benefits (“GMIB”) fees
(“GMIB Fees”).
The following are significant items excluded from total expenses in calculating
adjusted earnings:
•Amounts associated with benefits related to GMIBs (“GMIB Costs”);
•Amounts associated with periodic crediting rate adjustments based on the total
return of a contractually referenced pool of assets (“Market Value
Adjustments”); and
•Amortization of DAC related to (i) net investment gains (losses), (ii) net
derivative gains (losses) and (iii) GMIB Fees and GMIB Costs.
The tax impact of the adjustments discussed above is calculated net of the
statutory tax rate, which could differ from our effective tax rate.
38
——————————————————————————–
Table of Contents
We present adjusted earnings in a manner consistent with management’s view of
the primary business activities that drive the profitability of our core
businesses. The following table illustrates how each component of adjusted
earnings is calculated from the GAAP statement of operations line items:
Component of Adjusted Earnings How Derived from GAAP (1)
(i) Fee income (i) Universal life and investment-type policy fees (excluding
(a) unearned revenue adjustments related to net investment
gains (losses) and net derivative gains (losses) and (b)
GMIB Fees) plus Other revenues and amortization of deferred
gain on reinsurance.
(ii) Net investment spread (ii) Net investment income plus Investment Hedge Adjustments and
interest received on ceded fixed annuity reinsurance
deposit funds reduced by Interest credited to policyholder
account balances and interest on future policy benefits.
(iii)
Insurance-related activities (iii) Premiums less Policyholder benefits and claims (excluding
(a) GMIB Costs, (b) Market Value Adjustments, (c) interest
on future policy benefits and (d) amortization of deferred
gain on reinsurance) plus the pass through of performance
of ceded separate account assets.
(iv) Amortization of DAC (iv) Amortization of DAC (excluding amounts related to (a) net
investment gains (losses), (b) net derivative gains
(losses) and (c) GMIB Fees and GMIB Costs).
(v) Other expenses, net of DAC capitalization (v)
Other expenses reduced by capitalization of DAC.
(vi)
Provision for income tax expense (benefit) (vi)
Tax impact of the above items.
_______________
(1)Italicized items indicate GAAP statement of operations line items.
Consistent with GAAP guidance for segment reporting, adjusted earnings is also
our GAAP measure of segment performance. Accordingly, we report adjusted
earnings by segment in Note 2 of the Notes to the Interim Condensed Financial
Statements.
39
——————————————————————————–
Table of Contents
Results of Operations
Results for the Three Months Ended
Unless otherwise noted, all amounts in the following discussions of our results
of operations are stated before income tax except for adjusted earnings, which
are presented net of income tax.
Three Months Ended
March 31,
2022 2021
(In millions)
Revenues
Premiums $ 3 $ 5
Universal life and investment-type product policy fees 25 25
Net investment income 43 37
Other revenues (23) (23)
Net investment gains (losses) (7) 1
Net derivative gains (losses) (40) (85)
Total revenues 1 (40)
Expenses
Policyholder benefits and claims 7 (6)
Interest credited to policyholder account balances 12 13
Capitalization of DAC (13) (14)
Amortization of DAC 1 (3)
Other expenses 32 33
Total expenses 39 23
Income (loss) before provision for income tax (38)
(63)
Provision for income tax expense (benefit) (9) (14) Net income (loss)$ (29) $ (49)
The components of net income (loss) were as follows:
Three Months Ended
March 31,
2022 2021
(In millions)
GMLB Riders $ (34) $ (64)
Other derivative instruments 2
3
Net investment gains (losses) (7)
1
Pre-tax adjusted earnings 1
(3)
Income (loss) before provision for income tax (38)
(63)
Provision for income tax expense (benefit) (9) (14) Net income (loss)$ (29) $ (49)
Three Months Ended
2021
Loss before provision for income tax was$38 million ($29 million , net of income tax), a lower loss of$25 million ($20 million , net of income tax) from a loss before provision for income tax of$63 million ($49 million , net of income tax) in the prior period.
The increase in income before provision for income tax was driven by the
following net favorable items:
•a net favorable change in guaranteed minimum living benefits ("GMLB") riders
("GMLB Riders") from lower relative equity markets and higher interest rates
resulting in:
•favorable changes to the estimated fair value of the embedded derivative
liabilities associated with Shield Level Annuities (“Shield”); and
•a favorable change in ceded reinsurance;
40
——————————————————————————–
Table of Contents
partially offset by
•unfavorable changes to the estimated fair value of our GMLB hedges;
•an unfavorable change to the estimated fair value of variable annuity liability
reserves; and
•an unfavorable change to GMLB DAC; and
•higher pre-tax adjusted earnings, as discussed in greater detail below.
The increase in income before provision for income tax was partially offset by net investment losses reflecting current period net losses on sales of fixed maturity securities compared to prior period net gains. The provision for income tax resulted in an effective tax rate of 24% in the current period compared to 22% in the prior period. The increase in the effective tax rate was driven by higher pre-tax adjusted earnings, as discussed in greater detail below. Our effective tax rate differs from the statutory tax rate primarily due to the impacts of the dividends received deduction and tax credits.
Reconciliation of Net Income (Loss) to Adjusted Earnings
The reconciliation of net income (loss) to adjusted earnings was as follows:
Three Months Ended
March 31,
2022 2021
(In millions)
Net income (loss) $ (29) $ (49)
Add: Provision for income tax expense (benefit) (9)
(14)
Income (loss) before provision for income tax (38)
(63)
Less: GMLB Riders (34)
(64)
Less: Other derivative instruments 2
3
Less: Net investment gains (losses) (7)
1
Pre-tax adjusted earnings 1
(3)
Less: Provision for income tax expense (benefit) - (1) Adjusted earnings$ 1 $ (2)
Results for the Three Months Ended
The components of adjusted earnings were as follows:
Three Months Ended
March 31,
2022 2021
(In millions)
Fee income $ 32 $ 34
Net investment spread 26 19
Insurance-related activities (29) (24)
Amortization of DAC (9) (13)
Other expenses, net of DAC capitalization (19)
(19)
Pre-tax adjusted earnings 1
(3)
Provision for income tax expense (benefit) - (1) Adjusted earnings$ 1 $ (2)
Three Months Ended
2021
Adjusted earnings were
million
Key favorable impacts were:
•higher net investment spread due to higher average invested assets resulting
from positive net flows in the general account; and
41
——————————————————————————–
Table of Contents
•lower amortization of DAC driven by a decrease in equity market performance
resulting in favorable changes to our Shield business.
Key unfavorable impacts were:
•higher costs associated with insurance-related activities driven by higher paid
claims, net of reinsurance; and
•lower asset-based fees resulting from lower average separate account balances,
a portion of which is offset in other expenses.
The increase in pre-tax adjusted earnings resulted in a lower effective tax rate
in the current period compared to the prior period. Our effective tax rate
differs from the statutory tax rate primarily due to the impacts of the
dividends received deduction and tax credits.
Note Regarding Forward-Looking Statements
This report and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as "anticipate," "estimate," "expect," "project," "may," "will," "could," "intend," "goal," "target," "guidance," "forecast," "preliminary," "objective," "continue," "aim," "plan," "believe" and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, financial projections, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, as well as trends in operating and financial results. Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of BHNY. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others:
•differences between actual experience and actuarial assumptions and the
effectiveness of our actuarial models;
•the impact on earnings, capitalization and statutory capital and greater
volatility of our results due to guarantees within certain of our products;
•the impact of the ongoing COVID-19 pandemic;
•the potential material adverse effect of changes in accounting standards, practices or policies applicable to us, including changes in the accounting for long-duration contracts;
•loss of business and other negative impacts resulting from a downgrade or a
potential downgrade in our financial strength ratings;
•the availability of reinsurance and the ability of the counterparties to our
reinsurance or indemnification arrangements to perform their obligations
thereunder;
•heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, financial strength ratings, e-business capabilities and name recognition;
•our ability to market and distribute our products through distribution
channels;
•any failure of third parties to provide services we need, any failure of the
practices and procedures of such third parties and any inability to obtain
information or assistance we need from third parties;
•the risks associated with climate change;
•the adverse impact on liabilities for policyholder claims as a result of
extreme mortality events;
•the impact of adverse capital and credit market conditions, including with
respect to our ability to meet liquidity needs and access capital;
42
——————————————————————————–
Table of Contents
•the impact of economic conditions in the capital markets and the
global economy, as well as geo-political events, military actions or
catastrophic events, on our investment portfolio, including on realized and
unrealized losses and impairments, net investment spread and net investment
income;
•the impact of events that adversely affect issuers, guarantors or collateral relating to our investments or our derivatives counterparties, on impairments, valuation allowances, reserves, net investment income and changes in unrealized gain or loss positions;
•the impact of changes in regulation and in supervisory and enforcement policies
on our insurance business or other operations;
•the potential material negative tax impact of potential future tax legislation
that could make some of our products less attractive to consumers;
•the effectiveness of our policies and procedures in managing risk;
•the loss or disclosure of confidential information, damage to our reputation and impairment of our ability to conduct business effectively as a result of any failure in cyber- or other information security systems; •whether all or any portion of the tax consequences of our separation from MetLife, Inc. (together with its subsidiaries and affiliates, "MetLife") are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us;
•the uncertainty of the outcome of any disputes with MetLife over tax-related or
other matters and agreements or disagreements regarding MetLife’s or our
obligations under our other agreements; and
•other factors described in this report and from time to time in documents that
we file with the
For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our 2021 Annual Report, particularly in the sections entitled "Risk Factors" and "Quantitative and Qualitative Disclosures About Market Risk," as well as in our other subsequent filings with theSEC . Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.
[ad_2]
Source link
